American Pharma, American Bioscence complete merger

April 19, 2006 – American Pharmaceutical Partners Inc., a specialty injectable pharmaceutical company, and its parent company American BioScience, a biotechnology company, announced that the merger between the two companies has been completed. The combined company is named Abraxis BioScience Inc. and its common stock will trade as of April 19 on the Nasdaq National Market under the new ticker symbol ABBI.

The company said it believes it is well positioned for long term growth by capitalizing on the financial position of its injectables business and the potential of Abraxane (paclitaxel protein-bound particles) as well as its clinical programs and product development pipeline.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.